Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN
Khattar Jack A. exercised options for 29,849 Supernus Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 12, 2026 · Filed Aug 14, 2026
On Aug 12, 2026, Khattar Jack A. (Director, President, CEO) exercised options for 29,849 Supernus Pharmaceuticals, Inc. shares, leaving 1,258,351 shares. Filed Aug 14, 2026 (Form 4).
- Options exercised
- 29,849 shares
- Holding after
- 1,258,351 shares
- Trading plan
- No
- Role
- Director, President, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 29,849 | 1,270,993 | Direct | |
| Aug 12, 2026 | Common Stock | Shares withheld for tax | 12,642 | US$46.57 | 1,258,351 | Direct |